Infection Control and Epidemiology has published “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations…
On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral…
On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis who…
Infection Control and Epidemiology has published “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus…